Bills/H.Res. 803119th Congress

Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.

House: Referred
Cosponsors
11
Introduced
2025-10-10
Last action
2025-10-10

Referred to the House Committee on Energy and Commerce.

Sign in to view Hilltelligence’s plain-English summary.

Action Timeline
  1. HouseLatest

    Submitted in House

  2. House

    Referred to the House Committee on Energy and Commerce.

Sign in to view Hilltelligence’s passage-probability analysis.

Topics

Policy area

Sign in to view Hilltelligence’s potential-cosponsor analysis.